Sep. 18, 2014
Arysta LifeScience Limited announced its new organizational accountability for biostimulant, biocontrol and innovation nutriment products in the French market.
Following the acquisition of Goёmar by Arysta LifeScience in March, the Goёmar sales team in France will now be handling several key Arysta LifeScience biostimulant and biocontrol products, including CARPOVIRUSINE®, CARPOVIRUSINE® EVO2, OSTRINIL® and RHYNCHOTRAK®.
The biostimulant and biocontrol markets in France have seen rapid growth in recent years and are expected to continue to grow strongly. In turn, Arysta LifeScience has realigned the distribution of biostimulant and biocontrol products with the Goёmar team.
“The synergies between our two sales teams in the French market are undeniable,” said Vivien Rousselin, French Sales Director, Arysta LifeScience. “Goëmar’s distribution of our BioSolutions products will help strengthen their value.”
“Arysta LifeScience’s biocontrol portfolio effectively completes our VACCIPLANT® range of products to meet the high demand of the French market,” added David Gaillet, French Sales Director, Goёmar. “By offering a larger portfolio, we are able to accelerate the development of bioperformance in agriculture with both economic and environmental efficiency.